Tuesday , December 1 2020

Vaccination of 1,700 women against papiloma in Costa Rica People



In order to avoid cervical cancer, 1,700 young women and young women from San Carlos are vaccinated against the human papillomavirus (HPV).

The work is carried out by the Costa Rica Agency for Biomedical Research (ACIB) as part of the study to show that an individual dose is as effective as application two.

The vaccination process started on 7 December and will run until February 2020 while participants will be recruited and then follow for a further four years.

Data from the National Tumoria Registry shows that 25 women Alajuela have a canton of women from cervical cancer between 2011 and 2015. That is, a rate of 5.6 cases per 100,000 women per annum.

"Cervical cancer continues to claim the lives of hundreds of thousands of women every year, especially in the poorest countries, this is, despite the fact that we have tools to prevent, such as early detection and & # 39; the HPV vaccine, "said Paula González, director of ACIB.

"The vaccine does not apply in all the countries that they need because of its high cost and two classes, so we conducted the study to show that one dose is adequate and we can protect more of women all over the world, "he added.

Vaccines are applied in the One and Two Comparison Study against HPV (Escuding), which includes 24,000 young women and young people, aged 12 to 20.

This dose will be accepted by women from 50 cantons across the country, except Limón province due to the complexity of transmission and samples.

So far, only 6,500 24,000 women have been taken to take part in the process.

At the World Health Organization, under 15s are recommended to apply two doses and to include the vaccine in national immunization programs in each country.

The cervical cancer vaccine is part of the national free vaccination program in 80 countries. In Costa Rica it will be approved by the Ministry of Health and will be included in Costa Rica Social Security Fund (CCSS) programs for 10 year olds, starting in 2019.


Source link